FR2070149A1 - Hypocalcemiant calcitonin m derivatives - Google Patents
Hypocalcemiant calcitonin m derivativesInfo
- Publication number
- FR2070149A1 FR2070149A1 FR7037801A FR7037801A FR2070149A1 FR 2070149 A1 FR2070149 A1 FR 2070149A1 FR 7037801 A FR7037801 A FR 7037801A FR 7037801 A FR7037801 A FR 7037801A FR 2070149 A1 FR2070149 A1 FR 2070149A1
- Authority
- FR
- France
- Prior art keywords
- thr
- gly
- leucine
- phe
- phenylalanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000055006 Calcitonin Human genes 0.000 title abstract 2
- 108060001064 Calcitonin Proteins 0.000 title abstract 2
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title abstract 2
- 229960004015 calcitonin Drugs 0.000 title abstract 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 8
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 4
- 235000019454 L-leucine Nutrition 0.000 abstract 4
- 239000004395 L-leucine Substances 0.000 abstract 4
- 229960003136 leucine Drugs 0.000 abstract 4
- 229960005190 phenylalanine Drugs 0.000 abstract 3
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 2
- 229940024606 amino acid Drugs 0.000 abstract 2
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 229960002885 histidine Drugs 0.000 abstract 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 1
- SNDPXSYFESPGGJ-BYPYZUCNSA-N L-2-aminopentanoic acid Chemical compound CCC[C@H](N)C(O)=O SNDPXSYFESPGGJ-BYPYZUCNSA-N 0.000 abstract 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 abstract 1
- QWCKQJZIFLGMSD-VKHMYHEASA-N L-alpha-aminobutyric acid Chemical compound CC[C@H](N)C(O)=O QWCKQJZIFLGMSD-VKHMYHEASA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229930064664 L-arginine Natural products 0.000 abstract 1
- 235000014852 L-arginine Nutrition 0.000 abstract 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 229930182816 L-glutamine Natural products 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- 229930182844 L-isoleucine Natural products 0.000 abstract 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 1
- 229930195722 L-methionine Natural products 0.000 abstract 1
- SNDPXSYFESPGGJ-UHFFFAOYSA-N L-norVal-OH Natural products CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 abstract 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 abstract 1
- 239000004473 Threonine Substances 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 229960005261 aspartic acid Drugs 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 229960004452 methionine Drugs 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 abstract 1
- 229960002898 threonine Drugs 0.000 abstract 1
- 229960004441 tyrosine Drugs 0.000 abstract 1
- 229960004295 valine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/585—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1578669A CH523868A (de) | 1969-10-22 | 1969-10-22 | Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate |
| CH1014670A CH534663A (de) | 1969-10-22 | 1970-07-03 | Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2070149A1 true FR2070149A1 (en) | 1971-09-10 |
| FR2070149B1 FR2070149B1 (enrdf_load_stackoverflow) | 1974-05-24 |
Family
ID=25705993
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7037801A Granted FR2070149A1 (en) | 1969-10-22 | 1970-10-20 | Hypocalcemiant calcitonin m derivatives |
Country Status (11)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5359152U (enrdf_load_stackoverflow) * | 1976-10-20 | 1978-05-19 | ||
| JPS60500054A (ja) * | 1983-02-15 | 1985-01-17 | ア−マ−・フア−マシユ−テイカル・カンパニ− | デス−アスパラギン−３−カルシトニン |
| JPS60500055A (ja) * | 1983-02-15 | 1985-01-17 | ア−マ−・ファ−マシュ−ティカル・カンパニ− | グリシン−８−カルシトニン |
-
1970
- 1970-07-03 CH CH1014670A patent/CH534663A/de unknown
- 1970-10-14 CA CA095,500A patent/CA974229A/en not_active Expired
- 1970-10-14 DE DE19702050434 patent/DE2050434A1/de active Pending
- 1970-10-20 FR FR7037801A patent/FR2070149A1/fr active Granted
- 1970-10-20 SE SE14122/70A patent/SE365795B/xx unknown
- 1970-10-21 NL NL7015406A patent/NL7015406A/xx unknown
- 1970-10-21 BE BE757786D patent/BE757786A/xx unknown
- 1970-10-21 AT AT948270A patent/AT301772B/de not_active IP Right Cessation
- 1970-10-21 AT AT545371A patent/AT311568B/de not_active IP Right Cessation
- 1970-10-22 OA OA54064A patent/OA04245A/xx unknown
- 1970-10-22 CS CS7112A patent/CS152375B2/cs unknown
- 1970-10-22 JP JP45092498A patent/JPS4843918B1/ja active Pending
- 1970-10-22 CS CS5369*BA patent/CS152376B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CS152376B2 (enrdf_load_stackoverflow) | 1973-12-19 |
| AT311568B (de) | 1973-11-26 |
| SE365795B (enrdf_load_stackoverflow) | 1974-04-01 |
| CH534663A (de) | 1973-03-15 |
| NL7015406A (enrdf_load_stackoverflow) | 1971-04-26 |
| DE2050434A1 (de) | 1971-05-06 |
| JPS4843918B1 (enrdf_load_stackoverflow) | 1973-12-21 |
| CA974229A (en) | 1975-09-09 |
| OA04245A (fr) | 1979-12-31 |
| SU439088A3 (enrdf_load_stackoverflow) | 1974-08-05 |
| BE757786A (fr) | 1971-04-21 |
| CS152375B2 (enrdf_load_stackoverflow) | 1973-12-19 |
| FR2070149B1 (enrdf_load_stackoverflow) | 1974-05-24 |
| AT301772B (de) | 1972-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1507951A (en) | Amino acid formulations | |
| SE7907393L (sv) | Aminosyralosning for intravenos neringstillforsel | |
| GB1511302A (en) | Pharmaceutical compositions comprising amino acid analogues | |
| GB1399888A (en) | Injectable amino acid composition | |
| GB1489447A (en) | Amino acid supplements | |
| JPS568312A (en) | Amino acid pharmaceutical preparation | |
| GB987800A (en) | Improvements in or relating to toilet preparations containing amino acids | |
| IE39051B1 (en) | New peptides and processes for their manufacture | |
| FR2070149A1 (en) | Hypocalcemiant calcitonin m derivatives | |
| DE59001192D1 (de) | Waessrige zusammensetzung fuer die parenterale ernaehrung. | |
| GB1460108A (en) | Pharmaceutical preparations containing aspirin or indomethacin | |
| GB1348438A (en) | N-blocked amino acids | |
| FR2316933A1 (fr) | Melanges de l-aminoacides et leur utilisation therapeutique pour le traitement d'insuffisances hepatiques et renales. | |
| GB1309150A (en) | Acthactive peptides and process for their manufacture | |
| JPS57209211A (en) | Antimicrobial composition | |
| KR900013872A (ko) | 영양 조성물 | |
| GB1397680A (en) | Aqueous lipid emulsion for parenteral alimentation | |
| JPS5681515A (en) | Amino acid transfusion | |
| ES384703A1 (es) | Procedimiento para la obtencion de derivados peptidos. | |
| GB900115A (en) | Improvements in or relating to trypsin solutions | |
| Rao et al. | Estimation of partial molar volumes of α-amino acids in water | |
| GB938782A (en) | Process for n-trifluoracetylating amino acids and peptides | |
| GB1166403A (en) | Process for the manufacture of Amino Acid Derivatives | |
| GB1353827A (en) | Acthaction peptides and process for their manufacture | |
| US3639383A (en) | Complexes of a.c.t.h. peptides and polyphosphoric acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CD | Change of name or company name | ||
| ST | Notification of lapse |